Screener
Aptevo Therapeutics APVO Q4 2025 Annual earnings
Reported March 20, 2026 · Before market open
EPS$1,684.47Beat by $1,692.56
EPS estimate-$8.09
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$3.72
Versus estimates
Diluted EPS
FAQ
- When did Aptevo Therapeutics report Q4 2025 earnings?
- Aptevo Therapeutics (APVO) reported Q4 2025 earnings on March 20, 2026 before market open.
- What were Aptevo Therapeutics's Q4 2025 revenue and EPS?
- Aptevo Therapeutics reported eps of $1684.47 for Q4 2025.
- Did Aptevo Therapeutics beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-8.09 by $1692.56.
- Where can I find Aptevo Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-126278) directly on SEC EDGAR. The filing index links above go to sec.gov.
